Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02922894 · ClinicalTrials.gov registry record · Phase 4

Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury

A Phase 4 study of Spinal Cord Injury and Sleep Apnea, sponsored by John D. Dingell VA Medical Center.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target
1
Study location

NCT02922894 is a Phase 4 study of Spinal Cord Injury and Sleep Apnea that is actively recruiting participants, run by John D. Dingell VA Medical Center. The registered enrollment target is 100 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02922894, a Phase 4 study of Spinal Cord Injury and Sleep Apnea, is actively recruiting participants, sponsored by John D. Dingell VA Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).

Interventions

  • DRUG Placebo
  • DRUG Trazodone
  • PROCEDURE Acute episodic hypoxia
  • PROCEDURE Supplemental oxygen
  • PROCEDURE Sham

Study Locations (1)

Michigan

  • John D. Dingell VA Medical Center - Detroit

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-06-09
Est. Completion 2026-06-30
Phase Phase 4

What the Registry Record Tells You About NCT02922894

The ClinicalTrials.gov registry entry for NCT02922894 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (18% higher). The listed sponsor is John D. Dingell VA Medical Center, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT02922894 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02922894 about?

NCT02922894 is a clinical study titled "Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury". This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).

What is the current status of trial NCT02922894?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2017-06-09. Estimated completion is 2026-06-30.

What conditions does trial NCT02922894 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Sleep Apnea.

What interventions are being tested in trial NCT02922894?

The interventions under investigation include: Placebo (DRUG), Trazodone (DRUG), Acute episodic hypoxia (PROCEDURE), Supplemental oxygen (PROCEDURE), Sham (PROCEDURE).

Who is sponsoring clinical trial NCT02922894?

This trial is sponsored by John D. Dingell VA Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02922894 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.